Showing results (51-60 of 424) with videos related to
Sort By:
Pageof 43
Comparative Hepatology|September 25, 2004
Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis CThierry Poynard, Françoise Imbert-Bismut, Mona Munteanu, et al.Hepatology (Baltimore, Md.)|May 25, 2002
Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosisVlad Ratziu, Luminita Bonyhay, Vincent Di Martino, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 30, 2011
Pharmacological therapy for non-alcoholic steatohepatitis: How efficient are thiazolidinediones?Vlad Ratziu, Loredana PienarHepatology International|July 24, 2015
Pharmacological agents for nonalcoholic steatohepatitisMaeva Guillaume, Vlad RatziuComparative Hepatology|June 25, 2004
Intra-individual fasting versus postprandial variation of biochemical markers of liver fibrosis (FibroTest) and activity (ActiTest)Mona Munteanu, Djamila Messous, Dominique Thabut, et al.European Journal of Gastroenterology & Hepatology|February 7, 2018
Diagnostic performance of a new noninvasive test for nonalcoholic steatohepatitis using a simplified histological referenceThierry Poynard, Mona Munteanu, Frederic Charlotte, et al.Clinics in Liver Disease|April 6, 2023
Future Treatment Options and Regimens for Nonalcoholic Fatty Liver DiseaseSven Francque, Vlad RatziuDigestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 14, 2005
Treatment of cirrhotic patients in the pegylated interferon eraThierry PoynardClinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 21, 2012
Liver biopsy analysis has a low level of performance for diagnosis of intermediate stages of fibrosisThierry Poynard, Gilles Lenaour, Jean Christophe Vaillant, et al.Seminars in Liver Disease|September 4, 2004
Treatment of hepatitis C virus: the first decadeThierry PoynardPageof 43